Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial of decitabine and ECF chemotherapy for advanced cancer of the food pipe (oesophageal cancer)
This trial was looking at a drug called decitabine in combination with ECF chemotherapy for advanced cancer of the food pipe (oesophageal cancer).
Doctors often treat oesophageal cancer with chemotherapy and surgery. One of the most common types of chemotherapy for oesophageal cancer is a combination of drugs called ECF. This is the chemotherapy drugs epirubicin, cisplatin and fluorouracil (5FU).
In this trial, doctors wanted to see if another drug called decitabine, made ECF work better. Decitabine works by changing the activity of some of the
The aims of the trial were to find out
- The best dose of decitabine to give
- What the side effects were
- How well decitabine and ECF worked together
Summary of results
Despite attempting to contact the trial team, we have been unable to get any results for this trial.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
MGI Pharma Inc